Nine Point Two Capital LLC Castle Biosciences Inc Transaction History

Nine Point Two Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $111,440 - $320,320	-6,965 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$39.06 - $67.58 $272,052 - $470,694	6,965 New	6,965 $298,000
Q3 2021 Nov 10, 2021	SELL	$60.13 - $77.6 $169,506 - $218,754	-2,819 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$50.07 - $76.78 $141,147 - $216,442	2,819 New	2,819 $206,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $729M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nine Point Two Capital LLC with notifications on news.